Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?

Publikation: Bidrag til tidsskrift › Leder › Forskning

Standard

Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? / Ashina, Messoud; Martelletti, Paolo.

I: The Journal of Headache and Pain, Bind 19, Nr. 1, 33, 2018.

Publikation: Bidrag til tidsskrift › Leder › Forskning

Harvard

Ashina, M & Martelletti, P 2018, 'Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?', The Journal of Headache and Pain, bind 19, nr. 1, 33. https://doi.org/10.1186/s10194-018-0860-4

APA

Ashina, M., & Martelletti, P. (2018). Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? The Journal of Headache and Pain, 19(1), [33]. https://doi.org/10.1186/s10194-018-0860-4

Vancouver

Ashina M, Martelletti P. Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches? The Journal of Headache and Pain. 2018;19(1). 33. https://doi.org/10.1186/s10194-018-0860-4

Author

Ashina, Messoud ; Martelletti, Paolo. / Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?. I: The Journal of Headache and Pain. 2018 ; Bind 19, Nr. 1.

Bibtex

@article{46ba0f142ea9417fad24d3be916a671f,

title = "Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?",

author = "Messoud Ashina and Paolo Martelletti",

year = "2018",

doi = "10.1186/s10194-018-0860-4",

language = "English",

volume = "19",

journal = "Journal of Headache and Pain",

issn = "1129-2369",

publisher = "Springer",

number = "1",